A New York doctor’s alleged decision to send abortion pills to patients in Texas and Louisiana has pitted the Empire State’s ...
Entero Therapeutics has named Richard Paolone as interim chief executive.
BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...
A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
9d
New Vision on MSNUK-based Ugandan develops groundbreaking cancer drugAs a young girl in Kampala, Karmali Rashida would read stories about medicine and the human body. The deep curiosity about healing sparked something in her, a fascination with science that would one ...
Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a pioneering clinical trial of its gene-edited xenotransplantation kidney, named UKidney, ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
United Therapeutics will sponsor the Tyvaso DPI ... in one place, collects the vast history o ...
BEIJING (Reuters) - Liang Wenfeng, the 39-year-old founder of Chinese AI startup DeepSeek ... noose of export controls imposed by the United States. Liang had kept an extremely low profile ...
As innovative drug delivery platforms beyond GalNac continue to emerge and novel chemical modifications are discovered, the potential for RNAi therapeutics to treat a plethora of diseases grows. Now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results